Trial Profile
Phase I trial of an oncolytic virus [Prorvlysin] for prostate cancer.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Jan 2012
Price :
$35
*
At a glance
- Drugs Oncolytic viruses (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 25 Jan 2012 Status changed from planning to recruiting.
- 25 Jan 2012 Planned number of patients changed to 15.
- 27 Sep 2011 New trial record